相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Venetoclax in Patients with Previously Treated Chronic Lymphocytic Leukemia
Andrew W. Roberts et al.
CLINICAL CANCER RESEARCH (2017)
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
Andras Kotschy et al.
NATURE (2016)
Mito-priming as a method to engineer Bcl-2 addiction
Jonathan Lopez et al.
NATURE COMMUNICATIONS (2016)
Tight Sequestration of BH3 Proteins by BCL-xL at Subcellular Membranes Contributes to Apoptotic Resistance
Jessie Pecot et al.
CELL REPORTS (2016)
Constitutive BAK activation as a determinant of drug sensitivity in malignant lymphohematopoietic cells
Haiming Dai et al.
GENES & DEVELOPMENT (2015)
An interconnected hierarchical model of cell death regulation by the BCL-2 family
Hui-Chen Chen et al.
NATURE CELL BIOLOGY (2015)
Bid chimeras indicate that most BH3-only proteins can directly activate Bak and Bax, and show no preference for Bak versus Bax
C. Hockings et al.
CELL DEATH & DISEASE (2015)
In non-transformed cells Bak activates upon loss of anti-apoptotic Bcl-XL and Mcl-1 but in the absence of active BH3-only proteins
D. Senft et al.
CELL DEATH & DISEASE (2015)
Dissociation of Bak α1 helix from the core and latch domains is required for apoptosis
Amber E. Alsop et al.
NATURE COMMUNICATIONS (2015)
Lipid-Dependent Bimodal MCL1 Membrane Activity
Olatz Landeta et al.
ACS CHEMICAL BIOLOGY (2014)
Apoptosis Regulation at the Mitochondrial Outer Membrane
Laura A. Gillies et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2014)
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
Peter E. Czabotar et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Enhanced stability of Mcl1, a prosurvival Bcl2 relative, blunts stress-induced apoptosis, causes male sterility, and promotes tumorigenesis
Toru Okamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
BID Preferentially Activates BAK while BIM Preferentially Activates BAX, Affecting Chemotherapy Response
Kristopher A. Sarosiek et al.
MOLECULAR CELL (2013)
BAK/BAX activation and cytochrome c release assays using isolated mitochondria
Thibaud T. Renault et al.
METHODS (2013)
BH3-only proteins are tail-anchored in the outer mitochondrial membrane and can initiate the activation of Bax
F. Wilfling et al.
CELL DEATH AND DIFFERENTIATION (2012)
Predominant requirement of Bax for apoptosis in HCT116 cells is determined by Mcl-1's inhibitory effect on Bak
C. Wang et al.
ONCOGENE (2012)
Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX
Bonsu Ku et al.
CELL RESEARCH (2011)
Apoptosis and oncogenesis: give and take in the BCL-2 family
Fabien Llambi et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2011)
Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases
Andreas Strasser et al.
EMBO JOURNAL (2011)
BH3 Domains other than Bim and Bid Can Directly Activate Bax/Bak
Han Du et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Mutation to Bax beyond the BH3 Domain Disrupts Interactions with Pro-survival Proteins and Promotes Apoptosis
Peter E. Czabotar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
A Unified Model of Mammalian BCL-2 Protein Family Interactions at the Mitochondria
Fabien Llambi et al.
MOLECULAR CELL (2011)
BAX unleashed: the biochemical transformation of an inactive cytosolic monomer into a toxic mitochondrial pore
Loren D. Walensky et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
Inhibition of Bak Activation by VDAC2 Is Dependent on the Bak Transmembrane Anchor
Michael Lazarou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma
Bernhard Gillissen et al.
JOURNAL OF CELL BIOLOGY (2010)
The BCL-2 Family Reunion
Jerry E. Chipuk et al.
MOLECULAR CELL (2010)
Mechanisms by which Bak and Bax permeabilise mitochondria during apoptosis
Grant Dewson et al.
JOURNAL OF CELL SCIENCE (2009)
NF-κB1 and c-Rel cooperate to promote the survival of TLR4-activated B cells by neutralizing Bim via distinct mechanisms
Ashish Banerjee et al.
BLOOD (2008)
ABT-263: A potent and orally bioavailable Bcl-2 family inhibitor
Christin Tse et al.
CANCER RESEARCH (2008)
Activity of the Bcl-2 family inhibitor ABT-263 in a panel of small cell lung cancer xenograft models
Alex R. Shoemaker et al.
CLINICAL CANCER RESEARCH (2008)
BIM and tBID are not mechanistically equivalent when assisting BAX to permeabilize bilayer membranes
Oihana Terrones et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation
Erinna F. Lee et al.
JOURNAL OF CELL BIOLOGY (2008)
To trigger apoptosis, Bak exposes its BH3 domain and homodimerizes via BH3: Groove interactions
Grant Dewson et al.
MOLECULAR CELL (2008)
BCL-2 family antagonists for cancer therapy
Guillaume Lessene et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Inducible and reversible gene silencing by stable integration of an shRNA-encoding lentivirus in transgenic rats
Marco J. Herold et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Apoptosis is triggered when prosurvival Bcl-2 proteins cannot restrain Bax
Jamie I. Fletchera et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Bcl-XL inhibits membrane permeabilization by competing with Bax
Lieven P. Billen et al.
PLOS BIOLOGY (2008)
MCL-1 as a buffer for proapoptotic BCL-2 family members during TRAIL-induced apoptosis - A mechanistic basis for sorafenib (bay 43-9006)-induced trail sensitization
Xue Wei Meng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Embedded together: The life and death consequences of interaction of the Bcl-2 family with membranes
Brian Leber et al.
APOPTOSIS (2007)
Mitochondrial permeabilization relies on BH3 ligands engaging multiple prosurvival Bcl-2 relatives, not Bak
Rachel T. Uren et al.
JOURNAL OF CELL BIOLOGY (2007)
The BH3-only protein bid is dispensable for DNA darnage- and replicative stress-induced apoptosis or cell-cycle arrest
Thomas Kaufmann et al.
CELL (2007)
Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak
Simon N. Willis et al.
SCIENCE (2007)
A membrane-targeted BID BCL-2 homology 3 peptide is sufficient for high potency activation of BAX in vitro
Kyoung Joon Oh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized
Mark F. van Delft et al.
CANCER CELL (2006)
Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia
Marina Konopleva et al.
CANCER CELL (2006)
Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members
Michael Certo et al.
CANCER CELL (2006)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
BH3 domains of BH3-only proteins differentially regulate bax-mediated mitochondrial membrane permeabilization both directly and indirectly
T Kuwana et al.
MOLECULAR CELL (2005)
Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function
L Chen et al.
MOLECULAR CELL (2005)
Bim is a suppressor of Myc-induced mouse B cell leukemia
A Egle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics
A Letai et al.
CANCER CELL (2002)
Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax
H LeBlanc et al.
NATURE MEDICINE (2002)
分享论文
